The Efficacy of Dequalinium Chloride Against Vulvovaginitis in Pregnancy
DOI:
https://doi.org/10.25077/aoj.9.1.49-62.2025Keywords:
Vulvovaginitis, pregnancy, dequalinium chloride, metronidazole, nystatinAbstract
Introduction: Vulvovaginitis affects pregnancy outcomes and managing it involves the use of metronidazole or nystatin, which can cause local or systemic side effects. Dequalinium chloride (DQC) is suggested as a new treatment option for vulvovaginitis during pregnancy with minimal side effects.
Objective: To compare the effectiveness of dequalinium chloride (DQC) versus metronidazole + nystatin (MN) in treating vulvovaginitis in pregnant women during their second and third trimesters.
Method: A single-blind randomized controlled trial was conducted at the Andalas Public Health Center, Padang, from January to May 2024. Pregnant women in their second and third trimesters, meeting the inclusion and exclusion criteria, were enrolled. The participants were randomly assigned to either the DQC or MN group. Vaginal swabs were taken before and after a 6-day treatment, and PCR analysis was performed.
Results: Eighteen patients were treated with DQC and MN. Most participants had bacterial vaginosis (DQC 78%, MN 83%), with half having candidiasis (DQC and MN 50%) and fewer cases of trichomoniasis (28% in both groups). Significant improvements were seen in the DQC group for symptoms (p=0.000), Gardnerella vaginalis (p=0.035), and Candida albicans (p=0.021). In the MN group, significant improvements were noted for symptoms (p=0.000) and Gardnerella vaginalis (p=0.002). No significant differences were observed between the groups for symptom resolution or microbial reduction.
Conclusion: DQC is as effective as metronidazole + nystatin in treating bacterial vaginosis and candidiasis in pregnancy.
Keywords: Vulvovaginitis, pregnancy, dequalinium chloride, metronidazole, nystatin
References
Abou Chacra L, Fenollar F, Diop K. Bacterial Vaginosis: What Do We Currently Know? Front Cell Infect Microbiol. 2021;11:672429.
MojganTansaz, Soheila A, Hamed H, Fazele Heydarian M, Homa H. Vaginitis: Etiology and Role of Oxidative Stress, Inflammation and Antioxidants Therapy. Reprod Med Int. 2021;4(014):1–8.
Casanova R. Beckmann and Ling’s obstetrics and gynecology. Lippincott Williams & Wilkins; 2018.
Venugopal S, Gopalan K, Devi A, Kavitha A. Epidemiology and clinico-investigative study of organisms causing vaginal discharge. Indian J Sex Transm Dis AIDS. 2017;38(1):69-75. doi:10.4103/0253-7184.203433
Coudray MS, Madhivanan P. Bacterial vaginosis-A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2020 Feb;245:143–8.
Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas R V. High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis. Sex Transm Dis [Internet]. 2019;46(5). Available from: https://journals.lww.com/stdjournal/Fulltext/2019/05000/High_Global_Bu rden_and_Costs_of_Bacterial.5.aspx
Arfiputri DS, Hidayati AN, Handayani S, Ervianti E. RISK FACTORS OF VULVOVAGINAL CANDIDIASIS IN DERMATO-VENEREOLOGY OUTPATIENTS CLINIC OF SOETOMO GENERAL HOSPITAL, SURABAYA, INDONESIA. African J Infect Dis. 2018;12(1 Suppl):90–4.
Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339–47.
Kissinger PJ, Gaydos CA, Seña AC, McClelland RS, Soper D, Secor WE, dkk. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. Clinical Infectious Diseases. 2022; 74: S152–61
Febria C. Hubungan tingkat pengetahuan remaja putri dengan kejadian keputihan pada siswi-siswi MTsN Koto Tangah Padang. Jurnal Menara Medika. 2020; 2(2):87-93.
Khadawardi K. Prevalence of Abnormal Vaginal Discharge among Pregnant Women. Med. J. Cairo Univ. 2020; 88(2): 677-683.
Shawaky SM, Al Shammari MMA, Sewelliam MS, Ghazal AAER, Amer AN. A study on vaginitis among pregnant and non-pregnant females in Alexandria, Egypt: An unexpected high rate of mixed vaginal infection. AIMS Microbiol. 2022;8(2):167-177. Published 2022 May 5. doi:10.3934/microbiol.2022014
Sobel JD, Subramanian C, Foxman B, Fairfax M, Gygax SE. Mixed vaginitis-more than coinfection and with therapeutic implications. Curr Infect Dis Rep. 2013;15(2):104-108. doi:10.1007/s11908-013-0325-5
Mohanty T, Doke PP, Khuroo SR. Effect of bacterial vaginosis on preterm birth: a meta-analysis. Arch Gynecol Obstet. 2022;1–9.
Wiraguna AAGP, Rusyati L, i Dewa Ayu V. Bacterial vaginosis as a risk factor of preterm premature rupture of membrane (PPROM). Bali Dermatology Venereol J. 2019 Jul 14;1.
Khaskheli M, Baloch S, Baloch AS, Shah SGS. Vaginal discharge during pregnancy and associated adverse maternal and perinatal outcomes. Pak J Med Sci. 2021;37(5):1302-1308. doi:10.12669/pjms.37.5.4187
Li H, Dong M, Xie W, et al. Mixed Vaginitis in the Third Trimester of Pregnancy Is Associated With Adverse Pregnancy Outcomes: A Cross-Sectional Study. Front Cell Infect Microbiol. 2022;12:798738. Published 2022 Mar 28. doi:10.3389/fcimb.2022.798738
Paladine HL, Desai UA. Vaginitis: diagnosis and treatment. Am Fam Physician. 2018;97(5):321–9.
Hainer BL, Gibson M V. Vaginitis: diagnosis and treatment. Am Fam Physician. 2011;83(7):807–15.
Kemenkes RI. Pedoman nasional penanganan infeksi menular seksual. Jakarta Kemenkes RI. 2016;
Van Schalkwyk J, Yudin MH, Allen V, Bouchard C, Boucher M, Boucoiran I, et al. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. J Obstet Gynaecol Canada. 2015;37(3):266–74.
Bradshaw CS, Sobel JD. Current Treatment of Bacterial Vaginosis—Limitations and Need for Innovation. The Journal of Infectious Diseases. 2016; 214: S14-28.
Verwijs MC, Agaba SK, Darby AC, van de Wijgert JHHM. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure. Am J Obstet Gynecol. 2020;222(2):157.e1-157.e13. doi:10.1016/j.ajog.2019.08.008
Qulu WP, Mzobe G, Mtshali A, et al. Metronidazole Treatment Failure and Persistent BV Lead to Increased Frequencies of Activated T- and Dendritic-Cell Subsets. Microorganisms. 2023;11(11):2643. Published 2023 Oct 27. doi:10.3390/microorganisms11112643
Ajiji P, Uzunali A, Ripoche E, Vittaz E, Vial T, Maison P. Investigating the efficacy and safety of metronidazole during pregnancy; A systematic review and meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021; 11(10). https://doi.org/10.1016/j.eurox.2021.100128
Farr, A, Effendy, I, Frey Tirri, B, et al. Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k). Mycoses. 2021; 64: 583–602. https://doi.org/10.1111/myc.13248
Phillips NA, Bachmann G, Haefner H, Martens M, Stockdale C. Topical Treatment of Recurrent Vulvovaginal Candidiasis: An Expert Consensus. Women’s Health Reports. 2022; 3: 38-43.
Schalkwyk J, Yudin M. Vulvovaginitis: Screening for and Management of Trichomoniasis, Vulvovaginal Candidiasis, and Bacterial Vaginosis. SOGC Clinical practice guideline. 2015;320.
Dequalinium for bacterial vaginosis. Drug Ther Bull. 2017 May;55(5):54– 7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mila Permata Sari, Dovy Djanas, Andani Eka Putra
This work is licensed under a Creative Commons Attribution 4.0 International License.
